Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
Official title: Implementation Science to Understand and Design Stakeholder Informed Innovative Interventions to Improve Adolescent and Youth HIV Prevention and Care Continuums in Rural and Urban Uganda
Funded at Mu-Jhu Care · NIH-11644068 · Data updated 2026-11-12
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mu-Jhu Care NIH-funded |
| Lab location | 1 site (Kampala, Uganda) |
| Project start | September 8, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $216,390 |
| NIH project number | 3UG1HD113241-04S3 |
| Project ID | NIH-11644068 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adolescents and young adults aged 15-24 in Uganda who are at high risk for HIV or are living with HIV and need support to stay adherent and virally suppressed.
✕Less likely to help
Young people outside the 15-24 age range or those not engaged in HIV prevention or care activities may not benefit from these specific interventions.
What this research studies
This project works with adolescents and young adults in Uganda to improve how HIV prevention and care services are delivered and used. It will test community-based models and long-acting cabotegravir (CAB-LA) delivery to make PrEP and viral suppression more accessible and acceptable for youth. Using real-world settings, the study combines screening for HIV risk, youth-friendly trials, and MOH-approved service delivery approaches to support sustained engagement in prevention and care. Researchers will assess how well these interventions work in reducing barriers and improving outcomes along the HIV care cascade.
Why it matters
Potential benefit: If successful, it could make HIV prevention and treatment more effective for Ugandan youth, reducing new infections and helping more HIV-positive young people achieve viral suppression.
How similar studies have gone: Previous work suggests tailored, youth-focused delivery models can improve uptake and adherence, with further evidence needed for long-acting PrEP in real-world settings.
Where this research is happening
-
Mu-Jhu Care
Kampala, Uganda Active
Researchers
- Principal investigator: Musoke, Philippa — Mu-Jhu Care
- Study coordinator: Musoke, Philippa
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Improving HIV Prevention and Care for Ugandan Adolescents and Young Adults
A Uganda-based research effort aims to boost HIV prevention and care outcomes for 15-24 year-olds by testing practical, community-based strategies to increase PrEP use and viral suppression.
-
Adolescent and Youth HIV Prevention and Care Improvements in Uganda
A UG1 grant is testing ways to help Ugandan teens and young adults (ages 15-24) prevent HIV and stay healthy if they have HIV, using new long-acting PrEP and community care approaches.
-
Malkia Klabu: safer, youth-friendly pharmacies to boost HIV prevention for AGYW in Tanzania
A Tanzania-based project tests a youth-friendly pharmacy model to improve access to HIV prevention and sexual health services for adolescent girls and young women.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan study tests new ways to help teens and young adults (ages 15–24) prevent HIV and stay healthy if they are living with HIV, using community-based options and long-acting PrEP.
-
Improving HIV prevention and care for adolescents and young adults in Uganda
This project will offer long-acting injectable HIV prevention and youth-centered care approaches to help adolescents and young adults in Uganda start and stay on effective prevention and treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.